Drawing for PROSED

USPTO serial 77212062

PROSED

Reviewed by CopyMark Law Group

Reg. 3391322Status 711
Filing date
Status date
Registration date
Mar 4, 2008
Examiner
LOTT, JASON E
Law office
TMO LAW OFFICE 113

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PROSED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arne M. Olson

Arne M. Olson OLSON & CEPURITIS, LTD.20 North Wacker Drive36th FloorChicago, IL 60606

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparation, namely, a urinary anti-infective and anti-spasmodicSECTION 7(e) - CANCELLEDDec 31, 1964

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 9, 2014C7..CANCELLED SECTION 7-TOTAL—
Dec 8, 2014ES7STEAS SECTION 7 SURRENDER RECEIVED—
Jul 30, 2014EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Mar 22, 2014PRA8POST REGISTRATION ACTION MAILED - SEC. 8—
Mar 22, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 4, 2014ES8RTEAS SECTION 8 RECEIVED—
Apr 15, 2008CORVREVIEW OF CORRESPONDENCE COMPLETE—
Apr 4, 2008MAILPAPER RECEIVED—
Mar 4, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 18, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 28, 2007NPUBNOTICE OF PUBLICATION—
Nov 9, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 9, 2007ALIEASSIGNED TO LIE—
Oct 24, 2007ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 9, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 1, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 1, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 1, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2007GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 26, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 24, 2007DOCKASSIGNED TO EXAMINER—
Jun 25, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance